PDS Biotechnology Corporation (PDSB)

PDS Biotechnology Balance Sheet

Financials in millions USD. Fiscal year is January - December.

Fiscal Year	TTM	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019
Period Ending	Sep 30, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020	Dec 31, 2019
Cash & Equivalents	-	56.56	73.82	65.24	28.84	12.16
Cash & Short-Term Investments	57.73	56.56	73.82	65.24	28.84	12.16
Cash Growth	6.42%	-23.38%	13.15%	126.23%	137.13%	11628.38%
Prepaid Expenses	-	2.49	2.66	1.6	1.5	2.31
Total Current Assets	-	59.06	76.48	66.84	30.34	14.47
Property, Plant & Equipment	-	0.34	0.53	0.36	0.55	0.02
Total Assets	-	59.39	77.01	67.2	30.89	14.49
Accounts Payable	-	6.98	1.22	1.31	1.42	1.2
Accrued Expenses	-	2.42	8.31	2.19	1.74	1.1
Short-Term Debt	-	4.17	-	-	-	-
Current Portion of Leases	-	0.06	0.29	0.26	0.12	-
Other Current Liabilities	-	-	-	-	-	0.5
Total Current Liabilities	-	13.63	9.82	3.76	3.27	2.79
Long-Term Debt	-	19.51	23.02	-	-	-
Long-Term Leases	-	0.12	0.16	0.23	0.49	-
Total Liabilities	-	33.26	33.01	3.99	3.76	2.79
Common Stock	-	0.01	0.01	0.01	0.01	0
Additional Paid-In Capital	-	170.62	145.55	123.9	70.91	40.63
Retained Earnings	-	-144.5	-101.56	-60.7	-43.79	-28.94
Shareholders' Equity	30.92	26.13	44	63.21	27.13	11.7
Total Liabilities & Equity	-	59.39	77.01	67.2	30.89	14.49
Total Debt	24.38	23.85	23.47	0.49	0.61	-
Net Cash (Debt)	33.36	32.71	50.35	64.75	28.23	12.16
Net Cash Growth	8.84%	-35.03%	-22.25%	129.38%	132.12%	16402.80%
Net Cash Per Share	0.95	1.06	1.76	2.53	1.69	2.50
Filing Date Shares Outstanding	36.81	36.68	30.72	28.45	22.26	5.28
Total Common Shares Outstanding	36.81	33.09	30.17	28.45	22.26	5.28
Working Capital	-	45.43	66.66	63.08	27.07	11.68
Book Value Per Share	0.84	0.79	1.46	2.22	1.22	2.21
Tangible Book Value	30.92	26.13	44	63.21	27.13	11.7
Tangible Book Value Per Share	0.84	0.79	1.46	2.22	1.22	2.21
Machinery	-	0.27	0.12	0.12	0.12	0.12

Source: S&P Capital IQ. Standard template. Financial Sources.